Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of the EB Subtype of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Gaixiang Xu, Wei Wang, Shuanghong Zhu, Kongfei Li, Xinping Zhou, Liya Ma, Li Ye, Chen Mei, Lu Wang, Lingxu Jiang, Haitao Meng, Wen-Juan Yu, Jie Jin, Hongyan Tong, Jian Huang

Blood (2023) 142 (Supplement 1): 6481.

https://doi.org/10.1182/blood-2023-184789

Published: 2023

Journal Articles

Risk Factors for Severe Infection and Unfavorable Outcomes in Hematologic Malignancy Patients with COVID-19 Inflection during the Omicron Era: A Chinese Single-Center Retrospective Study

Blood (2023) 142 (Supplement 1): 5384.

https://doi.org/10.1182/blood-2023-184470

Published: 2023

Journal Articles

Influenza Training of Granulopoiesis Promotes Long-Term Anti-Leukemia Activity

Yi Liu, Nianci Chen, Yile Zhou, Li Zhu, Zuopo Lv, Chenying Li, Jiansong Huang, Yanhong Tong, Haitao Meng, Jie Jin, Liangshun You

Blood (2023) 142 (Supplement 1): 3926.

https://doi.org/10.1182/blood-2023-179218

Published: 2023

Journal Articles

How Induction Cycles before Remission Influence Long-Term Survival in Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 6001.

https://doi.org/10.1182/blood-2023-186048

Published: 2023

Journal Articles

The ZR2-Minichop Study：Zanubrutinib, Lenalidomide, Rituximab, Cyclophosphamide, Vincristine, Epirubicin and Prednisone in Elderly Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Jianai Sun, Yi Xu, Min Yang, Huafeng Wang, Wenjuan Yu, Liangshun You, Haitao Meng, Chunmei Yang, Xinping Zhou, Li Li, De Zhou, Xiujing Ye, Hong-hu Zhu, Hongyan Tong, Jie Jin, Wanzhuo Xie

Blood (2022) 140 (Supplement 1): 3756.

https://doi.org/10.1182/blood-2022-158723

Published: 2022

Journal Articles

A Real World Study of Venetoclax Combined with Azacitidine in 64 Chinese Patients Newly Diagnosed Acute Myeloid Leukemia

Jiejing Qian, Jieyu Xu, Qing Hong, Yinjun Lou, Liping Mao, Weilai Xu, Min Yang, Wenjuan Yu, Haitao Meng, Wenyuan Mai, Xiujing Ye, Honghu Zhu, Jie Jin

Blood (2021) 138 (Supplement 1): 4414.

https://doi.org/10.1182/blood-2021-149523

Published: 2021

Journal Articles

The Final Analysis of Expand: A Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib (RUX) in Patients (pts) with Myelofibrosis (MF) and Low Platelet (PLT) Count (50 × 10 9 /L to < 100 × 10 9 /L) at Baseline

Paola Guglielmelli, MD, Jean-Jacques Kiladjian, MD PhD, Alessandro M. Vannucchi, MD, Ming-hui Duan, MD, Haitao Meng, MD PhD, Ling Pan, MD PhD, Guangsheng He, MD PhD, Srdan Verstovsek, MD PhD, Françoise Boyer-Perrard, MD, Fiorenza Barraco, MD, Dietger Niederwieser, MD PhD, Anna Marina Liberati, MD, Claire Harrison, DM, FRCP, FRCPath, Pantelia Roussou, MSc, Monika Wroclawska, MD, Kevin Majidi, Peter AW te Boekhorst, MD PhD, Heinz Gisslinger, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-137742

Published: 2020

Journal Articles

Two-Year Follow-up of Investigator-Initiated Phase 1 Trials of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells (CT053) in Relapsed/Refractory Multiple Myeloma

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-140156

Published: 2020

Journal Articles

Comparison of Subcutaneous Injection Versus Intravenous Infusion of Cytarabine for Induction Therapy in Young Adult Acute Myeloid Leukemia: Results of a Prospective, Multicenter, Noninferiority, Randomized Trial

Blood (2020) 136 (Supplement 1): 4.

https://doi.org/10.1182/blood-2020-143426

Published: 2020

Journal Articles

Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple Myeloma

Blood (2019) 134 (Supplement_1): 4435.

https://doi.org/10.1182/blood-2019-126104

Published: 2019

Journal Articles

Utility of Computed Tomography for the Diagnosis of Invasive Aspergillosis in Hematological Malignancy

Jie Jin, Wu Depei, Yang Liu, Si Si Pan, Jean Li Yan, Jalal A. Aram, Yin-jun Lou, Haitao Meng, Xiaochen Chen, Xian'an Zhang, Ilan S. Schwartz, Thomas F. Patterson

Blood (2017) 130 (Supplement 1): 2294.

https://doi.org/10.1182/blood.V130.Suppl_1.2294.2294

Published: 2017

Journal Articles

Prognostic Significance of IDH1 and IDH2 mutations in Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia

Blood (2016) 128 (22): 5058.

https://doi.org/10.1182/blood.V128.22.5058.5058

Published: 2016

Journal Articles

High Musashi-2 Expression Is an Unfavorable Prognostic Factor in Adult B-Cell Acute Lymphoblastic Leukemia.

Qitian Mu, Yungui Wang, Bing Chen, Wenbin Qian, MD, Haitao Meng, MD, Hongyan Tong, MD, Feifei Chen, Qiuling Ma, Wangmao Ni, Sai-Juan Chen, Jie Jin, MD

Blood (2012) 120 (21): 2508.

https://doi.org/10.1182/blood.V120.21.2508.2508

Published: 2012

Journal Articles

Homoharringtonine in Combination with Cytarabine and Aclarubicin in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia: a Single-Center Experience

Wenjuan Yu, MD, Liping Mao, MD, Jiejing Qian, MD, Wenbin Qian, MD, Haitao Meng, MD, Wenyuan Mai, MD, Hongyan Tong, MD, Yin Tong, MD, Jie Jin, MD

Blood (2011) 118 (21): 2595.

https://doi.org/10.1182/blood.V118.21.2595.2595

Published: 2011

Journal Articles

A Clinical Study of Bortezomib in Combination with Dexamethasone and/or Doxorubibcin for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Jie Jin, PhD, Jiejing Qian, Haitao Meng, Wenbin Qian, Hongyan Tong, Yin Tong, Liping Mao

Blood (2008) 112 (11): 5216.

https://doi.org/10.1182/blood.V112.11.5216.5216

Published: 2008

Journal Articles

Clinical Characteristics of T-Cell Lymphoma Associated Hemophagocytic Syndrome: Comparison of T-Cell Lymphoma with and without Hemophagocytic Syndrome.

Hongyan Tong, MD, PhD, Yanling Ren, MD, Feng Xiao, MD, Wenyuan Mai, MD, PhD, Haitao Meng, MD, PhD, Wenbin Qian, MD, PhD, Jie Jin, MD, PhD

Blood (2007) 110 (11): 3576.

https://doi.org/10.1182/blood.V110.11.3576.3576

Published: 2007

Journal Articles

Retrospective Study on T Cell Malignent Lymphoma: Classification, Manifestation, Laboratory Finding and Survival.

Hongyan Tong, MD, PhD, Feng Xiao, MD, Tieying Dai, MD, Jie Jin, MD,PhD, Haitao Meng, MD,PhD, Wenbing Qian, MD,PhD, Wenyuan Mai, MD,PhD, Fengjuan Zhang, MD, Hui Liu, MD

Blood (2006) 108 (11): 4652.

https://doi.org/10.1182/blood.V108.11.4652.4652

Published: 2006

Journal Articles

Therapy of Hereditary TTP with ADAMTS13 Deficiency - A Case Report and Review of the Literature.

Jian Huang, Jie Jin, Ph.D, Haitao Meng, Ph.D, Yuhong Zhou, Rongxi Yu, Fang Liu, Changgen Ruan, Ph.D

Blood (2005) 106 (11): 4085.

https://doi.org/10.1182/blood.V106.11.4085.4085

Published: 2005

NARROW

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of the EB Subtype of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Risk Factors for Severe Infection and Unfavorable Outcomes in Hematologic Malignancy Patients with COVID-19 Inflection during the Omicron Era: A Chinese Single-Center Retrospective Study

Influenza Training of Granulopoiesis Promotes Long-Term Anti-Leukemia Activity

How Induction Cycles before Remission Influence Long-Term Survival in Acute Myeloid Leukemia

The ZR2-Minichop Study：Zanubrutinib, Lenalidomide, Rituximab, Cyclophosphamide, Vincristine, Epirubicin and Prednisone in Elderly Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

A Real World Study of Venetoclax Combined with Azacitidine in 64 Chinese Patients Newly Diagnosed Acute Myeloid Leukemia

The Final Analysis of Expand: A Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib (RUX) in Patients (pts) with Myelofibrosis (MF) and Low Platelet (PLT) Count (50 × 10 9 /L to < 100 × 10 9 /L) at Baseline

Two-Year Follow-up of Investigator-Initiated Phase 1 Trials of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells (CT053) in Relapsed/Refractory Multiple Myeloma

Comparison of Subcutaneous Injection Versus Intravenous Infusion of Cytarabine for Induction Therapy in Young Adult Acute Myeloid Leukemia: Results of a Prospective, Multicenter, Noninferiority, Randomized Trial

Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple Myeloma

Utility of Computed Tomography for the Diagnosis of Invasive Aspergillosis in Hematological Malignancy

Prognostic Significance of IDH1 and IDH2 mutations in Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia

High Musashi-2 Expression Is an Unfavorable Prognostic Factor in Adult B-Cell Acute Lymphoblastic Leukemia.

Homoharringtonine in Combination with Cytarabine and Aclarubicin in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia: a Single-Center Experience

A Clinical Study of Bortezomib in Combination with Dexamethasone and/or Doxorubibcin for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Clinical Characteristics of T-Cell Lymphoma Associated Hemophagocytic Syndrome: Comparison of T-Cell Lymphoma with and without Hemophagocytic Syndrome.

Retrospective Study on T Cell Malignent Lymphoma: Classification, Manifestation, Laboratory Finding and Survival.

Therapy of Hereditary TTP with ADAMTS13 Deficiency - A Case Report and Review of the Literature.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only